newsfilter
← Latest News
GlobeNewswire·

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

MELBOURNE, Australia, March 05, 2025 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce it has entered into an